Skip to main content

Malignant Lymphomas in Immunocompromised Hosts, in Particular with AIDS

  • Conference paper
  • 40 Accesses

Part of the book series: ESO Monographs ((ESO MONOGRAPHS))

Abstract

Prior to the AIDS epidemic, malignant lymphomas, in particular non-Hodgkin’s lymphoma (NHL), were described in up to 30% of the patients with primary immunodeficiency disorders such as the X-linked lymphoproliferative syndrome or the Wiscott Aldrich syndrome. Moreover, patients with immune deficiency secondary to cytostatic anticancer therapy and also following organ transplantation, autoimmune diseases and connective tissue disorders are at increased risk of NHL The lymphomas which arise in all these settings and in patients with HIV infection have certain features in common, including 1) prevalence of high-grade pathological types, predominantly large cell and immunoblastic lymphomas, or small non-cleaved cell; 2) restriction to B-cell origin; 3) widely disseminated disease at presentation; 4) poor prognosis compared to patients with “common” lymphomas.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ziegler JL, Beckstead JA, Volberding PA et al: Non-Hodgkin lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 1984 (311):565–570

    Article  PubMed  CAS  Google Scholar 

  2. Knowles DM, Chamulak GA, Subar M et al: Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1987). Ann Intern Med 1988 (108): 744–753

    PubMed  CAS  Google Scholar 

  3. Lowenthal DA, Straus DJ, Campbell SW et al: AIDS-related lymphoid neoplasia. The Memorial Hospital experience. Cancer 1988 (61):2325–2337

    Article  PubMed  CAS  Google Scholar 

  4. Kaplan LD, Abrams Dl, Feigal E et al: AIDS-asso-ciated non-Hodgkin’s lymphoma in San Francisco. JAMA 1989 (261):719–724

    Article  PubMed  CAS  Google Scholar 

  5. Roithmann S, Toledano M, Tourani JM et al: HIV-associated non-Hodgkin’s lymphomas: clinical characteristics and outcome. The experience of the French Registry of HIV-associated tumors. Ann Oncol 1991 (2):289–295

    PubMed  CAS  Google Scholar 

  6. Levine AM, Sullivan-Halley J, Pike MC et al: Human immunodeficiency virus-related lymphoma - prognostic factors predictive of survival. Cancer 1991 (68):2466–2472

    Article  PubMed  CAS  Google Scholar 

  7. Pedersen C, Gerstoft J, Lundgren JD et al: HIV-associated lymphoma - histopathology and association with Epstein-Barr virus genome related to clinical, immunological and prognostic features. Eur J Cancer 1991 (27):1416–1423

    Article  PubMed  CAS  Google Scholar 

  8. Gill P, Levine A, Krailo M et al: AIDS-related malignant lymphoma: results of prospective treatment trials. J Clin Oncol 1987 (5): 1322–1328

    PubMed  CAS  Google Scholar 

  9. Monfardini S, Tirelli U, Vaccher E et al: Malignant lymphomas in patients with or at risk for AIDS. JNCI 1988 (80):855–860

    Google Scholar 

  10. Levine AM, Wernz JC, Kaplan L et al: Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective, multi-institutional trial. JAMA 1991 (266):84–88

    Article  PubMed  CAS  Google Scholar 

  11. Levine A: Epidemiology, clinical characteristics and management of AIDS-related lymphoma. Hemat/ Onc Clin of North Amer 1991 (2):331

    Google Scholar 

  12. Pluda J, Broder S, Yarchoan R: Therapy of AIDS and AIDS-associated neoplasms. In: Pinedo HM, Longo DL and Chabner BA (eds) Cancer Chemotherapy and Biological Response Modifiers Annual 13. Elsevier Science Publishers BV, Amsterdam 1992 pp 395–439

    Google Scholar 

  13. Northfelt D and Kaplan LD: Clinical aspects of AIDS-related non-Hodgkin’s lymphoma. Curr Opin Oncol 1991 (3):872–880

    Article  PubMed  CAS  Google Scholar 

  14. Boyle M, Swanson CE, Turner JJ et al: Definition of two distinct types of AIDS-associated non-Hodgkin lymphoma. Br J Haem 1990 (76):506–512

    Article  CAS  Google Scholar 

  15. Biggar RJ, Horm J, Goedert JJ, Melbye M: Cancer in a group at risk of acquired immunodeficiency syndrome (AIDS) through 1984. Am J Epidemiol 1987 (126):578–586

    PubMed  CAS  Google Scholar 

  16. Goldstein J, Dickson DW, Moser FG et al: Primary central nervous system lymphoma in acquired immune deficiency syndrome. Cancer 1991 (67): 2756–2765

    Article  PubMed  CAS  Google Scholar 

  17. Ziegler JL: “Biologic” differences in acquired immune deficiency syndrome-associated non-Hodgkin’s lymphomas? J Clin Oncol 1991 (8): 1329–1331

    Google Scholar 

  18. Kalter SP, Riggs SA, Cabanillas F et al: Aggressive non-Hodgkin’s lymphomas in immunocompromised homosexual males. Blood 1985 (3):655–659

    Google Scholar 

  19. Bermudez MA, Grant KM, Rodvien R, Mendes F: Non-Hodgkin’s lymphoma in a population with or at risk for acquired immunodeficiency syndrome: Indication for intensive chemotherapy. Am J Med 1989 (86):71–76

    Article  PubMed  CAS  Google Scholar 

  20. Monfardini S, Vaccher E, Foà R, Tirelli U: AIDS-associated non-Hodgkin’s lymphoma in Italy: intravenous drug users versus homosexual men. Ann Oncol 1990 (1):203–211

    PubMed  CAS  Google Scholar 

  21. Sawka CA, Shepherd FA, Brandwein J, Burkers RL, Sutton D, Warner E: Treatment of AIDS-related non-Hodgkin’s lymphoma with a twelve week chemotherapy program. Leukemia and Lymphoma 1992 (8):213–220

    Article  PubMed  CAS  Google Scholar 

  22. Matsushima Y, Kanzawa F, Hoshi A: Time-schedule dependency of the inhibiting activity of various anticancer drugs in the clonogenic assay. Cancer Chemother Pharmacol 1985 (14):104–107

    Article  PubMed  CAS  Google Scholar 

  23. Sparano JA, Wiernik PH, Strack M, Leaf A, Becker N, Valentine ES: Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus and human T-cell leukemia virus type I-related non-Hodgkin’s lymphoma: a highly active regimen. Blood 1993 (10):2810–2815

    Google Scholar 

  24. Taillan B, Garnier G, Ferrari E et al: MACOP-B chemotherapy for the treatment of high-grade lymphomas in patients with HIV-1 infection. Acta Haematol 1993 (89): 10–12

    Article  PubMed  CAS  Google Scholar 

  25. Lopez TM, Hagemeister FB, McLaughlin P et al: Small noncleaved cell lymphoma in adults: superior results for stages l-lll disease. J Clin Oncol 1990 (4):615–622

    Google Scholar 

  26. Straus DJ, Wong GY, Liu J et al: Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt’s type) in American adults: results with treatment designed for acute lymphoblastic leukemia. Am J Med 1991 (90):328

    PubMed  CAS  Google Scholar 

  27. Coiffier B, Gisselbrecht C, Herbrecht R et al: LNH-84: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. J Clin Oncol 1989 (7):1018–1026

    PubMed  CAS  Google Scholar 

  28. Gisselbrecht C, Oksenhendler E, Tirelli U et al: Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. Am J Med 1993 (95): 188–196

    Article  PubMed  CAS  Google Scholar 

  29. Tirelli U, Errante D, Oksenhendler E et al: Prospective study with combined low-dose chemotherapy and zidovudine in 37 patients with poorprognosis AIDS-related non-Hodgkin’s lymphoma. Ann Oncol 1992 (3):843–847

    PubMed  CAS  Google Scholar 

  30. Huhn D, Weiss R, Nerl C et al: HIV-related non-Hodgkin’s lymphoma: CHOP-induction and AZT/IFa-maintenance therapy. Proc ASCO 1993 (12):52 (abstract #12)

    Google Scholar 

  31. Levine AM, Katz-Willson E, Espina B et al: Low dose m-BACOD with concomitant dideoxyctidine (ddC) in AIDS related lymphoma. Blood 1992 (80/1 suppl 1): 328a (abstract #1301)

    Google Scholar 

  32. Kaplan LD, Kahn JO, Crowe S et al: Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin’s lymphoma: results of a randomized trial. J Clin Oncol 1991 (6):929–940

    Google Scholar 

  33. Walsh C, Wernz JC, Levine A et al: Phase I trial of m-BACOD and granulocyte macrophage colony stimulating factor in HIV-associated non-Hodgkin’s lymphoma. JAIDS 1993 (6):265–271

    CAS  Google Scholar 

  34. Hahn SM, Pluda J, Shay L et al: Treatment of AIDS-related non-Hodgkin’s lymphoma (NHL) with chemotherapy, AZT, and granulocyte-macrophage colony-stimulating factor (GM-CSF). VII International Conference on AIDS, Florence 16–21 June, 1991, p 274 (abstract WB 2368)

    Google Scholar 

  35. Tirelli U, Errante D, Vaccher E et al: Treatment of HIV-related non-Hodgkin’s lymphoma (NHL) with chemotherapy (CT) and G-CSF: reduction of hospitalization and toxicity with concomitant overall reduction in the cost. Proc ASCO 1993 (12):53 (abstract # 13)

    Google Scholar 

  36. Formenti SC, Gill PS, Lean E et al: Primary central nervous system lymphoma in AIDS: results of radiation therapy. Cancer 1989 (63):1101–1107

    Article  PubMed  CAS  Google Scholar 

  37. Baumgartner JE, Rachlin JR, Beckstead JH et al: Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 1990 (73):206–211

    Article  PubMed  CAS  Google Scholar 

  38. Remick SC, McSharry JJ, Wolf BC et al: Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related non-Hodgkin’s lymphoma. J Clin Oncol 1993 (9):1691–1702

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Tirelli, U., Vaccher, E. (1995). Malignant Lymphomas in Immunocompromised Hosts, in Particular with AIDS. In: Pangalis, G.A. (eds) Malignant Lymphomas: Biology and Treatment. ESO Monographs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79913-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-79913-6_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-79915-0

  • Online ISBN: 978-3-642-79913-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics